Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Starkey, Malcolm R ^a   Kim, Richard Y ^a   Beckett, Emma L ^a   Schilter, Heidi C ^b   Shim, Doris ^b   Essilfie, Ama Tawiah ^a   Nguyen, Duc H ^a   Beagley, Kenneth W ^c   Mattes, Joerg ^a,d   Mackay, Charles R ^e   Horvat, Jay C ^a   Hansbro, Philip M ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 15;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL FUNCTION; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; HELPER CELL; HEMATOPOIETIC CELL; LUNG INFECTION; MEDIASTINUM LYMPH NODE; MOUSE; NEWBORN; NONHUMAN; PROTEIN FUNCTION; TH2 CELL;

ANIMALS; ANIMALS, NEWBORN; ASTHMA; BONE MARROW TRANSPLANTATION; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FEMALE; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-13; INTERLEUKIN-5; MALE; MICE; MICE, INBRED BALB C; PNEUMONIA, BACTERIAL; PULMONARY ALVEOLI; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

BACTERIA (MICROORGANISMS); CHLAMYDIA MURIDARUM; MUS;

EID: 84864764856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042588     Document Type: Article

References (38)

1. Hansbro PM, Kaiko GE, Foster PS, (2011) Cytokine/anti-cytokine therapy- novel treatments for asthma Br J Pharmacol 163: 81-95.
2. Wills-Karp M, (2004) Interleukin-13 in asthma pathogenesis. Immunol Rev 202: 175-190.
3. Hansbro NG, Horvat JC, Wark PA, Hansbro PM, (2008) Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol Ther 117: 313-353.
4. Hansbro PM, Beagley KW, Horvat JC, Gibson PG, (2004) Role of atypical bacterial infection of the lung in predisposition/protection of asthma. Pharmacol Ther 101: 193-210.
5. Hansbro PM, Starkey MR, Kim RY, Foster PS, Horvat JC, (2012) Programming of the lung by early life infection. Journal of Developmental Origins of Health and Disease In press.
6. Horvat JC, Beagley KW, Wade MA, Preston JA, Hansbro NG, et al. (2007) Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med 176: 556-564.
7. Horvat JC, Starkey MR, Kim RY, Phipps S, Gibson PG, et al. (2010) Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J Allergy Clin Immunol 125: 617-625, 625 e611-625 e616.
8. Jupelli M, Murthy AK, Chaganty BK, Guentzel MN, Selby DM, et al. (2011) Neonatal chlamydial pneumonia induces altered respiratory structure and function lasting into adult life. Lab Invest 91: 1530-1539.
9. Thorburn AN, Hansbro PM, Gibson PG, (2009) Pneumococcal vaccines for allergic airways diseases. Expert Opin Biol Ther 9: 621-629.
10. Thorburn AN, Hansbro PM, (2010) Harnessing regulatory T cells to suppress asthma: from potential to therapy. Am J Respir Cell Mol Biol 43: 511-519.
11. Kaiko GE, Horvat JC, Beagley KW, Hansbro PM, (2008) Immunological decision-making: how does the immune system decide to mount a helper T-cell response Immunology 123: 326-338.
12. Patel KK, Vicencio AG, Du Z, Tsirilakis K, Salva PS, et al. (2010) Infectious Chlamydia pneumoniae is associated with elevated interleukin-8 and airway neutrophilia in children with refractory asthma. Pediatr Infect Dis J 29: 1093-1098.
13. Blasi F, (2004) Atypical pathogens and respiratory tract infections. Eur Respir J 24: 171-181.
14. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F, (2009) Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med 103: 309-316.
15. Grayston JT, (1992) Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 15: 757-761.
16. Kuo CC, Jackson LA, Campbell LA, Grayston JT, (1995) Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8: 451-461.
17. Rottenberg ME, Gigliotti-Rothfuchs A, Wigzell H, (2002) The role of IFN-gamma in the outcome of chlamydial infection. Curr Opin Immunol 14: 444-451.
18. Jupelli M, Guentzel MN, Meier PA, Zhong G, Murthy AK, et al. (2008) Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice. J Immunol 180: 4148-4155.
19. Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, et al. (2008) Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J Immunol 180: 2225-2232.
20. Beagley KW, Huston WM, Hansbro PM, Timms P, (2009) Chlamydial infection of immune cells: altered function and implications for disease. Crit Rev Immunol 29: 275-305.
21. Asquith KL, Horvat JC, Kaiko GE, Carey AJ, Beagley KW, et al. (2011) Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts. PLoS Pathog 7: e1001339.
22. King KY, Goodell MA, (2011) Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol 11: 685-692.
23. Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, et al. (2006) Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24: 801-812.
24. Belyaev NN, Brown DE, Diaz AI, Rae A, Jarra W, et al. (2010) Induction of an IL7-R(+)c-Kit(hi) myelolymphoid progenitor critically dependent on IFN-gamma signaling during acute malaria. Nat Immunol 11: 477-485.
25. Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA, (2010) Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 465: 793-797.
26. Skelding KA, Hickey DK, Horvat JC, Bao S, Roberts KG, et al. (2006) Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection. Vaccine 24: 355-366.
27. Shum BO, Mackay CR, Gorgun CZ, Frost MJ, Kumar RK, et al. (2006) The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J Clin Invest 116: 2183-2192.
28. Preston JA, Essilfie AT, Horvat JC, Wade MA, Beagley KW, et al. (2007) Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae. Vaccine 25: 8154-8162.
29. Preston JA, Thorburn AN, Starkey MR, Beckett EL, Horvat JC, et al. (2011) Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells. Eur Respir J 37: 53-64.
30. Horvat JC, Starkey MR, Kim RY, Beagley KW, Preston JA, et al. (2010) Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. J Immunol 184: 4159-4169.
31. Essilfie AT, Simpson JL, Horvat JC, Preston JA, Dunkley ML, et al. (2011) Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog 7: e1002244.
32. Essilfie AT, Simpson JL, Dunkley ML, Morgan LC, Oliver BG, et al. (2012) Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax.
33. Thorburn AN, O'Sullivan BJ, Thomas R, Kumar RK, Foster PS, et al. (2010) Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease. Thorax 65: 1053-1060.
34. Thorburn AN, Foster PS, Gibson PG, Hansbro PM, (2012) Components of Streptococcus pneumoniae Suppress Allergic Airways Disease and NKT Cells by Inducing Regulatory T Cells. J Immunol 188 In press.
35. Vanoirbeek JA, Rinaldi M, De Vooght V, Haenen S, Bobic S, et al. (2010) Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol 42: 96-104.
36. Saetta M, Finkelstein R, Cosio MG, (1994) Morphological and cellular basis for airflow limitation in smokers. Eur Respir J 7: 1505-1515.
37. Ueda Y, Yang K, Foster SJ, Kondo M, Kelsoe G, (2004) Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J Exp Med 199: 47-58.
38. Baldridge MT, King KY, Goodell MA, (2011) Inflammatory signals regulate hematopoietic stem cells. Trend Immunol 32: 57-65.